AI Portfolio Summary
In 2025 Q4, First Light Asset Management, LLC maintained a portfolio of 47 distinct positions. The most significant new addition to the portfolio was WAVE LIFE SCIENCES L, which now represents 2.41% of the total fund value. They heavily accumulated shares in NEOGENOMICS INC, increasing their position by 1.1%. Conversely, First Light Asset Management, LLC completely exited their position in PERFORMANT HEALTHCAR.
Total Positions
47
Quarter
2025 Q4
Top Holding
AXGN (13.1%)
Top 10 Concentration
57.2%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 47
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AXGN
AXOGEN INC
|
Healthcare | 13.10% | 9.76% |
#1
Prev: #1
|
5.3 | -572,404 | -9.9% |
P
S
|
5,233,326 | $171,286,760 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NEO
NEOGENOMICS INC
|
Healthcare | 9.02% | 7.22% |
#2
2
Prev: #4
|
5.6 | 107,794 | 1.1% |
P
S
|
10,035,063 | $118,012,341 | 2013 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SIBN
SI-BONE INC
|
Healthcare | 7.59% | 2.66% |
#3
11
Prev: #14
|
5.3 | 3,115,001 | 162.4% |
P
S
|
5,032,904 | $99,248,867 | 2019 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 5.67% | 3.20% |
#4
4
Prev: #8
|
4.4 | 167,597 | 30.9% |
P
S
|
709,141 | $74,225,788 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CNTA
CENTESSA PHARMA...
|
Healthcare | 4.36% | 8.31% |
#5
2
Prev: #3
|
1.9 | -1,356,876 | -37.3% |
P
S
|
2,278,940 | $56,996,289 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 4.25% | 3.70% |
#6
Prev: #6
|
3.8 | 252,747 | 26.8% |
P
S
|
1,194,263 | $55,592,943 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ATRC
ATRICURE INC
|
Healthcare | 3.56% | 2.96% |
#7
5
Prev: #12
|
3.5 | 285,083 | 32.0% |
P
S
|
1,175,445 | $46,500,604 | 2013 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 3.37% | 1.39% |
#8
19
Prev: #27
|
3.6 | 362,579 | 71.5% |
P
S
|
869,676 | $44,040,393 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 3.18% | 1.44% |
#9
17
Prev: #26
|
3.6 | 291,981 | 126.3% |
P
S
|
523,167 | $41,544,691 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 3.10% | 4.30% |
#10
5
Prev: #5
|
1.2 | -343 | -0.0% |
P
S
|
3,355,539 | $40,534,911 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 2.99% | 2.16% |
#11
7
Prev: #18
|
3.2 | 158,707 | 11.2% |
P
S
|
1,573,701 | $39,051,392 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 2.98% | 0.50% |
#12
24
Prev: #36
|
3.5 | 55,292 | 479.2% |
P
S
|
66,831 | $38,918,365 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TWST
TWIST BIOSCIENC...
|
Healthcare | 2.77% | 3.17% |
#13
4
Prev: #9
|
1.1 | -54,112 | -4.5% |
P
S
|
1,140,771 | $36,185,256 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLP
SIMULATIONS PLU...
|
Healthcare | 2.74% | 1.09% |
#14
16
Prev: #30
|
3.4 | 1,201,157 | 156.4% |
P
S
|
1,968,917 | $35,893,357 | 2018 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 2.42% | 1.72% |
#15
6
Prev: #21
|
3.2 | 115,360 | 63.9% |
P
S
|
295,844 | $31,667,142 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WVE
WAVE LIFE SCIEN...
|
Healthcare | 2.41% | — |
#16
Prev: #—
|
3.0 | 1,853,851 | no change |
NEW
|
1,853,851 | $31,515,467 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANAB
ANAPTYS BIO INC
|
Healthcare | 2.40% | 2.86% |
#17
4
Prev: #13
|
1.1 | -343,923 | -34.7% |
P
S
|
646,238 | $31,329,618 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HCAT
HEALTH CATALYST...
|
Healthcare | 2.36% | 3.61% |
#18
11
Prev: #7
|
1.0 | -525,279 | -3.9% |
P
S
|
12,910,941 | $30,857,149 | 2019 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GH
GUARDANT HEALTH
|
Healthcare | 2.30% | 1.65% |
#19
3
Prev: #22
|
2.9 | 14,750 | 5.3% |
P
S
|
294,751 | $30,105,867 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IRTC
IRHYTHM TECHNOL...
|
Healthcare | 2.09% | 2.51% |
#20
4
Prev: #16
|
0.8 | -1,228 | -0.8% |
P
S
|
153,871 | $27,302,870 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ESTA
ESTABLISHMENT L...
|
Healthcare | 2.08% | 1.62% |
#21
3
Prev: #24
|
0.9 | -45,276 | -10.8% |
P
S
|
373,082 | $27,190,216 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MASS
908 DEVICES INC
|
Healthcare | 1.94% | 2.07% |
#22
3
Prev: #19
|
3.1 | 2,325,690 | 92.6% |
P
S
|
4,836,186 | $25,389,977 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KRMD
KORU MEDICAL SY...
|
Healthcare | 1.87% | 1.63% |
#23
Prev: #23
|
0.8 | -317,225 | -7.0% |
P
S
|
4,210,512 | $24,463,075 | 2018 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TNDM
TANDEM DIABETES...
|
Healthcare | 1.83% | — |
#24
Prev: #—
|
2.7 | 1,089,493 | no change |
NEW
|
1,089,493 | $23,947,056 | 2018 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APGE
APOGEE THERAPEU...
|
Healthcare | 1.64% | — |
#25
Prev: #—
|
2.7 | 284,991 | no change |
NEW
|
284,991 | $21,511,121 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PHLT
PERFORMANT HEAL...
|
Unknown | 0.00% | 8.54% |
Sold All 😨
(Was: #2) |
0.3 | -11,718,612 | -100.0% |
CLOSED
|
— | $— | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LENZ
LENZ THERAPEUTI...
|
Healthcare | 0.00% | 3.04% |
Sold All 😨
(Was: #10) |
0.3 | -693,044 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CDTX
CIDARA THERAPEU...
|
Healthcare | 0.00% | 2.64% |
Sold All 😨
(Was: #15) |
0.3 | -292,657 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MRUS
MERUS NV
|
Healthcare | 0.00% | 1.99% |
Sold All 😨
(Was: #20) |
0.3 | -224,080 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ADMA
ADMA BIOLOGICS ...
|
Healthcare | 0.00% | 1.48% |
Sold All 😨
(Was: #25) |
0.3 | -1,069,233 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CAI
CARIS LIFE SCIE...
|
Healthcare | 0.00% | 1.12% |
Sold All 😨
(Was: #29) |
0.3 | -403,924 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.00% | 0.81% |
Sold All 😨
(Was: #31) |
0.3 | -285,699 | -100.0% |
CLOSED
|
— | $— | 2019 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SENS
SENSEONICS HOLD...
|
Healthcare | 0.00% | 0.74% |
Sold All 😨
(Was: #33) |
0.3 | -18,007,632 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RGEN
REPLIGEN CORP
|
Healthcare | 0.00% | 0.52% |
Sold All 😨
(Was: #34) |
0.3 | -41,427 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 0.00% | 0.52% |
Sold All 😨
(Was: #35) |
0.3 | -197,350 | -100.0% |
CLOSED
|
— | $— | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EVH
EVOLENT HEALTH ...
|
Healthcare | 0.00% | 0.43% |
Sold All 😨
(Was: #37) |
0.3 | -545,282 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALHC
ALIGNMENT HEALT...
|
Healthcare | 0.00% | 0.33% |
Sold All 😨
(Was: #38) |
0.3 | -203,138 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RDNT
RADNET INC
|
Healthcare | 0.00% | 0.30% |
Sold All 😨
(Was: #39) |
0.3 | -42,280 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TECX
TECTONIC THERAP...
|
Healthcare | 0.00% | 0.30% |
Sold All 😨
(Was: #40) |
0.3 | -202,393 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 47 holdings